MXPA04004757A - Uso de una ascomicina para el tratamiento de blefaritis. - Google Patents
Uso de una ascomicina para el tratamiento de blefaritis.Info
- Publication number
- MXPA04004757A MXPA04004757A MXPA04004757A MXPA04004757A MXPA04004757A MX PA04004757 A MXPA04004757 A MX PA04004757A MX PA04004757 A MXPA04004757 A MX PA04004757A MX PA04004757 A MXPA04004757 A MX PA04004757A MX PA04004757 A MXPA04004757 A MX PA04004757A
- Authority
- MX
- Mexico
- Prior art keywords
- ascomycin
- blepharitis
- treatment
- relates
- Prior art date
Links
- ZDQSOHOQTUFQEM-PKUCKEGBSA-N ascomycin Chemical compound C/C([C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@@H](OC)C[C@@H](C)C\C(C)=C/[C@H](C(C[C@H](O)[C@H]1C)=O)CC)=C\[C@@H]1CC[C@@H](O)[C@H](OC)C1 ZDQSOHOQTUFQEM-PKUCKEGBSA-N 0.000 title abstract 2
- ZDQSOHOQTUFQEM-XCXYXIJFSA-N ascomycin Natural products CC[C@H]1C=C(C)C[C@@H](C)C[C@@H](OC)[C@H]2O[C@@](O)([C@@H](C)C[C@H]2OC)C(=O)C(=O)N3CCCC[C@@H]3C(=O)O[C@H]([C@H](C)[C@@H](O)CC1=O)C(=C[C@@H]4CC[C@@H](O)[C@H](C4)OC)C ZDQSOHOQTUFQEM-XCXYXIJFSA-N 0.000 title abstract 2
- 208000010217 blepharitis Diseases 0.000 title abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Ophthalmology & Optometry (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Abstract
Esta invencion se refiere al uso de una ascomicina para el tratamiento de blefaritis.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01127546 | 2001-11-19 | ||
| PCT/EP2002/012921 WO2003043633A1 (en) | 2001-11-19 | 2002-11-18 | Use of an ascomycin for the treatment of blepharitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA04004757A true MXPA04004757A (es) | 2004-08-02 |
Family
ID=8179285
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA04004757A MXPA04004757A (es) | 2001-11-19 | 2002-11-18 | Uso de una ascomicina para el tratamiento de blefaritis. |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20050043286A1 (es) |
| EP (2) | EP1754482A1 (es) |
| JP (1) | JP2005511633A (es) |
| KR (1) | KR20040066825A (es) |
| CN (1) | CN1589144A (es) |
| AU (1) | AU2002366222A1 (es) |
| BR (1) | BR0214244A (es) |
| CA (1) | CA2467549A1 (es) |
| HU (1) | HUP0500698A2 (es) |
| IL (1) | IL161849A0 (es) |
| MX (1) | MXPA04004757A (es) |
| NO (1) | NO20042542L (es) |
| NZ (1) | NZ532963A (es) |
| PL (1) | PL368642A1 (es) |
| RU (1) | RU2004118424A (es) |
| WO (1) | WO2003043633A1 (es) |
| ZA (1) | ZA200403575B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3741367A1 (en) | 2019-05-21 | 2020-11-25 | Premark Pharma GmbH | Treatment of ocular disease |
| US11419886B2 (en) | 2020-11-23 | 2022-08-23 | Sight Sciences, Inc. | Formulations and methods for treating conditions of the eye |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0581959B1 (en) * | 1991-04-26 | 2001-01-17 | Fujisawa Pharmaceutical Co., Ltd. | Use of macrolide compounds for eye diseases |
| IL102414A (en) * | 1991-07-25 | 1996-08-04 | Univ Louisville Res Found | Medicinal preparations for the treatment of ocular inflammation, containing rapamycin |
| SE9904863D0 (sv) * | 1999-12-30 | 1999-12-30 | Medscand Medical Ab | New use |
| AR033151A1 (es) * | 2001-04-12 | 2003-12-03 | Sucampo Pharmaceuticals Inc | Agente para el tratamiento oftalmico topico de las enfermedades inflamatorias oculares |
-
2002
- 2002-11-18 RU RU2004118424/15A patent/RU2004118424A/ru not_active Application Discontinuation
- 2002-11-18 CN CNA028229975A patent/CN1589144A/zh active Pending
- 2002-11-18 KR KR10-2004-7007555A patent/KR20040066825A/ko not_active Application Discontinuation
- 2002-11-18 IL IL16184902A patent/IL161849A0/xx unknown
- 2002-11-18 AU AU2002366222A patent/AU2002366222A1/en not_active Abandoned
- 2002-11-18 WO PCT/EP2002/012921 patent/WO2003043633A1/en not_active Application Discontinuation
- 2002-11-18 EP EP06123838A patent/EP1754482A1/en not_active Withdrawn
- 2002-11-18 US US10/495,993 patent/US20050043286A1/en not_active Abandoned
- 2002-11-18 NZ NZ532963A patent/NZ532963A/en unknown
- 2002-11-18 CA CA002467549A patent/CA2467549A1/en not_active Abandoned
- 2002-11-18 HU HU0500698A patent/HUP0500698A2/hu unknown
- 2002-11-18 BR BR0214244-9A patent/BR0214244A/pt not_active IP Right Cessation
- 2002-11-18 EP EP02790400A patent/EP1450798A1/en not_active Withdrawn
- 2002-11-18 PL PL02368642A patent/PL368642A1/xx not_active Application Discontinuation
- 2002-11-18 MX MXPA04004757A patent/MXPA04004757A/es unknown
- 2002-11-18 JP JP2003545314A patent/JP2005511633A/ja active Pending
-
2004
- 2004-05-11 ZA ZA200403575A patent/ZA200403575B/en unknown
- 2004-06-17 NO NO20042542A patent/NO20042542L/no not_active Application Discontinuation
-
2007
- 2007-09-04 US US11/899,155 patent/US20080076793A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| IL161849A0 (en) | 2005-11-20 |
| RU2004118424A (ru) | 2005-05-10 |
| ZA200403575B (en) | 2006-07-26 |
| EP1450798A1 (en) | 2004-09-01 |
| US20050043286A1 (en) | 2005-02-24 |
| NZ532963A (en) | 2007-01-26 |
| AU2002366222A1 (en) | 2003-06-10 |
| JP2005511633A (ja) | 2005-04-28 |
| BR0214244A (pt) | 2004-09-21 |
| EP1754482A1 (en) | 2007-02-21 |
| KR20040066825A (ko) | 2004-07-27 |
| NO20042542L (no) | 2004-06-17 |
| CA2467549A1 (en) | 2003-05-30 |
| CN1589144A (zh) | 2005-03-02 |
| PL368642A1 (en) | 2005-04-04 |
| US20080076793A1 (en) | 2008-03-27 |
| HUP0500698A2 (en) | 2006-08-28 |
| WO2003043633A1 (en) | 2003-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG149063A1 (en) | Use of modified cyclosporins for the treatment of hcv disorders | |
| MXPA03011197A (es) | Benzoilsufonamidas y sulfonilbenzamidinas que se usan como agentes antitumorales. | |
| EP1432714A4 (en) | CHEMICAL COMPOUNDS | |
| IL160915A0 (en) | Indolizines inhibiting kinase proteins | |
| IL175770A0 (en) | Novel use of peptide compounds for treating central neuropathic pain | |
| NO2010020I2 (es) | ||
| TW200510407A (en) | Novel pyrrolodihydroisoquinolines as PDE 10 inhibitors | |
| PL1682530T3 (pl) | Podstawione pirolo-indole jako inhibitory PAI-1 | |
| MXPA04003886A (es) | Tiofen- y tiazolsulfonamidas como agentes antineoplasticos. | |
| TW200500071A (en) | Methods and reagents for treating infections of clostridium difficile and diseases associated therewith | |
| IL152411A0 (en) | Zolpidem hemitartrate | |
| PL371127A1 (en) | 6-aminomorphinane derivatives, method for the production and use thereof | |
| TW200510398A (en) | Novel compounds | |
| MXPA04003755A (es) | Endoprotesis vasculares. | |
| GB0207653D0 (en) | Methods of using lamellar bodies for therapeutic purposes | |
| MXPA03008946A (es) | Metodos para sintetizar compuestos que contienen fenol. | |
| AU2002231777A1 (en) | Use of mglur5 antagonists for the treatment of pruritic conditions | |
| MXPA04004090A (es) | Compuestos substituidos de 1h-quinolin-2-ona. | |
| MXPA04004757A (es) | Uso de una ascomicina para el tratamiento de blefaritis. | |
| MXPA05009428A (es) | Composiciones y metodos para prevenir y tratar enfermedades relacionadas con endotoxinas. | |
| EP1436279A4 (en) | CHEMICAL COMPOUNDS | |
| MXPA03005400A (es) | Metodo para preparacion de 11 (12)-pentadecen-15-olidos. | |
| SI1594879T1 (sl) | Postopek in intermediati za pripravo olanzapina | |
| ZA200400824B (en) | Pyridin-2-yl-methlyamine derivatives for treating opioid dependence. |